177 related articles for article (PubMed ID: 18597411)
21. Increased incidence of autoantibodies to interleukin-1a in rheumatoid arthritis with interstitial lung disease.
Maniwa K; Ogushi F; Tani K; Ohmoto Y; Muraguchi M; Sone S
Respirology; 2000 Dec; 5(4):315-20. PubMed ID: 11192540
[TBL] [Abstract][Full Text] [Related]
22. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
[TBL] [Abstract][Full Text] [Related]
23. Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis.
Simonini G; Matucci Cerinic M; Cimaz R; Anichini M; Cesaretti S; Zoppi M; Generini S; Falcini F
J Rheumatol; 2001 Jan; 28(1):198-203. PubMed ID: 11196525
[TBL] [Abstract][Full Text] [Related]
24. Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques.
Gonçalves I; Gronholdt ML; Söderberg I; Ares MP; Nordestgaard BG; Bentzon JF; Fredrikson GN; Nilsson J
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1250-5. PubMed ID: 15831809
[TBL] [Abstract][Full Text] [Related]
25. Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms.
Lindholt JS; Heegaard NH; Vammen S; Fasting H; Henneberg EW; Heickendorff L
Eur J Vasc Endovasc Surg; 2001 Jan; 21(1):51-6. PubMed ID: 11170878
[TBL] [Abstract][Full Text] [Related]
26. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies against oxidized LDL are associated with severe chest pain attacks in patients with coronary heart disease.
Luoma JS; Kareinen A; Närvänen O; Viitanen L; Laakso M; Ylä-Herttuala S
Free Radic Biol Med; 2005 Dec; 39(12):1660-5. PubMed ID: 16298691
[TBL] [Abstract][Full Text] [Related]
28. [Antibodies against low density oxidized lipoproteins in type 2 diabetics].
Malícková K; Skrha J; Janatková I; Vanková Z; Fucíková T
Epidemiol Mikrobiol Imunol; 2004 Aug; 53(3):131-5. PubMed ID: 15524272
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
[TBL] [Abstract][Full Text] [Related]
30. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.
Uusitupa MI; Niskanen L; Luoma J; Vilja P; Mercuri M; Rauramaa R; Ylä-Herttuala S
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1236-42. PubMed ID: 8857919
[TBL] [Abstract][Full Text] [Related]
32. Carotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertension.
Marchesi E; Martignoni A; Salvini M; Catalano O; Maggi E; Negro C; Traversa B; Bellomo G
J Hum Hypertens; 1996 Sep; 10(9):577-82. PubMed ID: 8953201
[TBL] [Abstract][Full Text] [Related]
33. Non-invasive imaging of vulnerable plaques by molecular targeting of oxidized LDL with tagged oxidation-specific antibodies.
Tsimikas S; Shaw PX
J Cell Biochem Suppl; 2002; 39():138-46. PubMed ID: 12552613
[TBL] [Abstract][Full Text] [Related]
34. Alcohol misuse increases serum antibodies to oxidized LDL and C-reactive protein.
Alho H; Sillanaukee P; Kalela A; Jaakkola O; Laine S; Nikkari ST
Alcohol Alcohol; 2004; 39(4):312-5. PubMed ID: 15208162
[TBL] [Abstract][Full Text] [Related]
35. Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosis.
Zehrfeld N; Abelmann M; Benz S; Zippel CL; Beider S; Kramer E; Seeliger T; Sogkas G; Gödecke V; Ahrenstorf G; Armbruster FP; Skripuletz T; Witte T; Derda AA; Sonnenschein K; Ernst D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38663882
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
Hulthe J
Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729
[TBL] [Abstract][Full Text] [Related]
37. Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males.
Barud W; Palusiński R; Bełtowski J; Wójcicka G
Atherosclerosis; 2002 Oct; 164(2):283-8. PubMed ID: 12204799
[TBL] [Abstract][Full Text] [Related]
38. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation.
Wong M; Toh L; Wilson A; Rowley K; Karschimkus C; Prior D; Romas E; Clemens L; Dragicevic G; Harianto H; Wicks I; McColl G; Best J; Jenkins A
Arthritis Rheum; 2003 Jan; 48(1):81-9. PubMed ID: 12528107
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to oxidized low-density lipoprotein in patients following coronary artery revascularization.
Miller ER; Erlinger TP; Blumenthal RS; Margolis S; Allen JK
Coron Artery Dis; 2003 Apr; 14(2):163-9. PubMed ID: 12655280
[TBL] [Abstract][Full Text] [Related]
40. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population.
Fukumoto M; Shoji T; Emoto M; Kawagishi T; Okuno Y; Nishizawa Y
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):703-7. PubMed ID: 10712394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
